DIN 02552310 — PRZ-SITAGLIPTIN-METFORMIN 50 MG; 850 MG
PRZ-SITAGLIPTIN-METFORMIN is a tablet of Sitagliptin / Metformin marketed by PHARMARIS CANADA INC. The full Sitagliptin / Metformin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02552310
- Brand name
- PRZ-SITAGLIPTIN-METFORMIN
- Active ingredient
- Sitagliptin / Metformin
- Strength
- 50 MG; 850 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- PHARMARIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor combined with a biguanide
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Sitagliptin / Metformin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02557746 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 1000 MG; 50 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02557711 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 50 MG; 500 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02557738 | AG-SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 50 MG; 850 MG | TABLET | ANGITA PHARMA INC. | MARKETED |
| 02509431 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50 MG; 1000 MG | TABLET | APOTEX INC | MARKETED |
| 02509415 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500 MG; 50 MG | TABLET | APOTEX INC | MARKETED |
| 02509423 | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850 MG; 50 MG | TABLET | APOTEX INC | MARKETED |
| 02435799 | APO-SITAGLIPTIN-METFORMIN | 1000 MG; 50 MG | TABLET | APOTEX INC | MARKETED |
| 02435772 | APO-SITAGLIPTIN-METFORMIN | 50 MG; 500 MG | TABLET | APOTEX INC | MARKETED |
| 02435780 | APO-SITAGLIPTIN-METFORMIN | 50 MG; 850 MG | TABLET | APOTEX INC | MARKETED |
| 02506297 | APO-SITAGLIPTIN/METFORMIN XR | 100 MG; 1000 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02506289 | APO-SITAGLIPTIN/METFORMIN XR | 1000 MG; 50 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02506270 | APO-SITAGLIPTIN/METFORMIN XR | 50 MG; 500 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02547821 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 50 MG; 1000 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02547805 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 50 MG; 500 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02547813 | AURO-SITAGLIPTIN HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE | 50 MG; 850 MG | TABLET | AURO PHARMA INC | MARKETED |
| 02556200 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 1000 MG; 50 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02556189 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 50 MG; 500 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02556197 | JAMP SITAGLIPTIN HYDROCHLORIDE / METFORMIN | 50 MG; 850 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED |
| 02333872 | JANUMET | 1000 MG; 50 MG | TABLET | MERCK CANADA INC | MARKETED |
| 02333856 | JANUMET | 50 MG; 500 MG | TABLET | MERCK CANADA INC | MARKETED |
| 02416808 | JANUMET XR | 100 MG; 1000 MG | TABLET (EXTENDED-RELEASE) | MERCK CANADA INC | MARKETED |
| 02416794 | JANUMET XR | 1000 MG; 50 MG | TABLET (EXTENDED-RELEASE) | MERCK CANADA INC | MARKETED |
| 02416786 | JANUMET XR | 500 MG; 50 MG | TABLET (EXTENDED-RELEASE) | MERCK CANADA INC | MARKETED |
| 02552833 | PRO-SITAGLIPTIN-METFORMIN | 50 MG; 1000 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02552825 | PRO-SITAGLIPTIN-METFORMIN | 50 MG; 850 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02552817 | PRO-SITAGLIPTIN-METFORMIN | 500 MG; 50 MG | TABLET | PRO DOC LIMITEE | MARKETED |
| 02552329 | PRZ-SITAGLIPTIN-METFORMIN | 50 MG; 1000 MG | TABLET | PHARMARIS CANADA INC | MARKETED |
| 02540134 | REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1000 MG; 50 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02540118 | REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 500 MG; 50 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02540126 | REDDY-SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | 850 MG; 50 MG | TABLET | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02503972 | SANDOZ SITAGLIPTIN-METFORMIN | 1000 MG; 50 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02503956 | SANDOZ SITAGLIPTIN-METFORMIN | 500 MG; 50 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02503964 | SANDOZ SITAGLIPTIN-METFORMIN | 850 MG; 50 MG | TABLET | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529122 | SANDOZ SITAGLIPTIN-METFORMIN XR | 100 MG; 1000 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529114 | SANDOZ SITAGLIPTIN-METFORMIN XR | 50 MG; 1000 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529106 | SANDOZ SITAGLIPTIN-METFORMIN XR | 50 MG; 500 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02529173 | SITAGLIPTIN-METFORMIN | 50 MG; 1000 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02529157 | SITAGLIPTIN-METFORMIN | 500 MG; 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02529165 | SITAGLIPTIN-METFORMIN | 850 MG; 50 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02560461 | SITAGLIPTIN/METFORMIN | 50 MG; 1000 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02560445 | SITAGLIPTIN/METFORMIN | 50 MG; 500 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02560453 | SITAGLIPTIN/METFORMIN | 50 MG; 850 MG | TABLET | SANIS HEALTH INC | MARKETED |
| 02520516 | TEVA-SITAGLIPTIN MALATE / METFORMIN | 50 MG; 1000 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02520494 | TEVA-SITAGLIPTIN MALATE / METFORMIN | 50 MG; 500 MG | TABLET | TEVA CANADA LIMITED | MARKETED |
| 02520508 | TEVA-SITAGLIPTIN MALATE / METFORMIN | 850 MG; 50 MG | TABLET | TEVA CANADA LIMITED | MARKETED |